Centrica plc (LON:CNA – Get Free Report) passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 136.95 ($1.83) and traded as high as GBX 160.85 ($2.15). Centrica shares last traded at GBX 159.15 ($2.13), with a volume of 36,171,680 shares changing hands.
Centrica Stock Performance
The company’s 50-day moving average price is GBX 148.52 and its two-hundred day moving average price is GBX 136.95. The company has a market cap of £7.93 billion, a P/E ratio of 7.56, a price-to-earnings-growth ratio of 0.45 and a beta of 1.08. The company has a current ratio of 1.77, a quick ratio of 0.40 and a debt-to-equity ratio of 66.48.
Centrica (LON:CNA – Get Free Report) last announced its earnings results on Thursday, February 20th. The integrated energy company reported GBX 19 ($0.25) EPS for the quarter. Centrica had a return on equity of 25.16% and a net margin of 5.39%.
Centrica Increases Dividend
Insider Buying and Selling at Centrica
In related news, insider Philippe Boisseau acquired 1,270 shares of the stock in a transaction that occurred on Wednesday, March 26th. The shares were purchased at an average cost of GBX 148 ($1.98) per share, with a total value of £1,879.60 ($2,509.81). Also, insider Amber Rudd acquired 1,483 shares of the company’s stock in a transaction on Tuesday, February 25th. The stock was bought at an average price of GBX 152 ($2.03) per share, for a total transaction of £2,254.16 ($3,009.96). Insiders have bought a total of 14,087 shares of company stock valued at $2,112,588 in the last three months. 0.20% of the stock is currently owned by company insiders.
About Centrica
Centrica is energising a greener, fairer future for our colleagues, customers and communities. Our integrated business operates across the energy value chain, with over ten million Retail customers, leading brands such as British Gas and Bord Gáis Energy, and the UK’s largest energy services workforce.
Featured Stories
- Five stocks we like better than Centrica
- How to Profit From Value Investing
- 3 Mid-Cap Medical Stocks Outperforming the Market
- Best Stocks Under $5.00
- The Top-Ranked Insider Buys From April by Market Cap
- With Risk Tolerance, One Size Does Not Fit All
- Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?
Receive News & Ratings for Centrica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centrica and related companies with MarketBeat.com's FREE daily email newsletter.